Read time:1 minute, 32 seconds

New Life Mexico believes that HIV-positive intended parents deserve an opportunity to have a family like everyone else in the world.

Yes, HIV-positive men can have biological children. Cutting-edge Assisted Reproductive Technologies (ART), in conjunction with advanced treatments and modern laboratory testing, makes it possible for an HIV-positive man to become a father. Additionally, HIV is an extremely manageable disease. Anti-retroviral therapy is used to control the virus so that HIV-positive individuals can live a longer, happier life, and enjoy it fully.

New Life Mexico, strongly believe that men who have HIV should be provided with the opportunity to become parents as much as anyone else. They have developed a unique surrogacy and egg donation program for HIV-positive intended fathers that has been successfully administered for years. To ensure the safety of all parties involved, the intended parents undergo a comprehensive health screening process before being admitted to the program. There are several criteria that an HIV-positive intended father is required to meet:

1/ He must be on anti-retroviral therapy.

2/ He must submit two serology tests with a difference of at least 6 months with an undetectable viral load.

3/ The last viral load must not be older than 6 months for the time of “sperm washing” date.

4/It is necessary to present a medical resume from the treating doctor (infectious disease specialist) where he/she confirms the health status of the intended father and provides his recommendation for acceptance into the program.

Programs available for HIV-positive intended fathers include the following:

Surrogacy
Surrogacy + Egg Donation (local or international traveling egg donors)
IVF for HIV-negative partner with or without Egg Donation
Surrogacy with frozen embryo
All above-mentioned programs with PGD for Gender Selection procedure added

For further information visit New Life Mexico.

 

About the author

Newsdesk

Leave a Reply

Your email address will not be published. Required fields are marked *

Close

Latest articles